Apoptosis in the development and maintenance of the immune system

Nature Immunology

Volumn 4, Issue 5, 2003, Pages 410-415

  Opferman, Joseph T ^a   Korsmeyer, Stanley J ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; AUTOIMMUNITY; CELL COMMUNICATION; CELL DEATH; CELL GROWTH; CELL MATURATION; CELL SURVIVAL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; APOPTOSIS; CASPASES; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; MICE; MODELS, IMMUNOLOGICAL; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0038393112     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni0503-410     Document Type: Review

References (101)

1. Vaux, D.L. & Korsmeyer, S.J. Cell death in development. Cell 96, 245-254 (1999).
2. Kerr, J.F., Wyllie, A.H. & Currie, A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).
3. Bakhshi, A. et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41, 899-906 (1985).
4. Cleary, M.L. & Sklar, J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 82, 7439-7443 (1985).
5. Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E. & Croce, C.M. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229, 1390-1393 (1985).
6. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D. & Korsmeyer, S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336 (1990).
7. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L. & Korsmeyer, S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251 (1993).
8. Vaux, D.L., Cory, S. & Adams, J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates With c-myc to immortalize pre-B cells. Nature 335, 440-442 (1988).
9. McDonnell, T.J. et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57, 79-88 (1989).
10. Gross, A., McDonnell, J.M. & Korsmeyer, S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911 (1999).
11. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462 (1995).
12. Owen, J.J. & Jenkinson, E.J. Apoptosis and T-cell repertoire selection in the thymus. Ann. NY Acad. Sci. 663, 305-310 (1992).
13. Jameson, S.C., Hogquist, K.A. & Bevan, M.J. Positive selection of thymocytes. Annu. Rev. Immunol. 13, 93-126 (1995).
14. Ashton-Rickardt, P.G. & Tonegawa, S.A. differential-avidity model for T-cell selection. Immunol. Today 15, 362-366 (1994).
15. Baird, A.M., Gerstein, R.M. & Berg, L.J. The role of cytokine receptor signaling in lymphocyte development. Curr. Opin. Immunol. 11, 157-166 (1999).
16. Baird, A.M., Lucas, J.A. & Berg, L.J. A profound deficiency in thymic progenitor cells in mice lacking Jak3. J. Immunol. 165, 3680-3688 (2000).
17. Nosaka, T. et al. Defective lymphoid development in mice lacking Jak3. Science 270, 800-802 (1995).
18. Thomis, D.C., Gurniak, C.B., Tivol, E., Sharpe, A.H. & Berg, L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270, 794-797 (1995).
19. Miyazaki, T. et al. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81, 223-231 (1995).
20. S) gene expression. Eur J. Immunol. 26, 294-299 (1996).
21. von Freeden-Jeffry, U., Solvason, N., Howard, M. & Murray, R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7, 147-154 (1997).
22. -/- mice. Cell 89, 1011-1019 (1997).
23. Akashi, K., Kondo, M., von Freeden-Jeffry, U., Murray, R. & Weissman, I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89, 1033-1041 (1997).
24. Thompson, C.B. et al. What keeps a resting T cell alive? Cold Spring Harb. Symp. Quant. Biol. 64, 383-387 (1999).
25. Ahmed, R. & Gray, D. Immunological memory and protective immunity: understanding their relation. Science 272, 54-60 (1996).
26. June, C.H., Ledbetter, J.A., Gillespie, M.M., Lindsten, T. & Thompson, C.B. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell Biol. 7, 4472-4481 (1987).
27. L. Immunity 3, 87-98 (1995).
28. Grillot, D.A. et al. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med. 183, 381-391 (1996).
29. Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946 (1995).
30. Boussiotis, V.A., Lee, B.J., Freeman, G.J., Gribben, J.G. & Nadler, L.M. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death. J. Immunol. 159, 3156-3167 (1997).
31. Gribben, J.G. et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA 92, 811-815 (1995).
32. + T cells in vivo by IL-15. Immunity 8, 591-599 (1998).
33. Schluns, K.S., Kieper, W.C., Jameson, S.C. & Lefrancois, L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1, 426-432 (2000).
34. Lodolce, J.P. et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669-676 (1998).
35. Wei, M.C. et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730 (2001).
36. Knudson, C.M.,Tung, K.S., Tourtellotte, W.G., Brown, G.A. & Korsmeyer, S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99 (1995).
37. Lindsten, T. et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell 6, 1389-1399 (2000).
38. Rathmell, J.C., Lindsten, T., Zong, W.X., Cinalli, R.M. & Thompson, C.B. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat. Immunol. 3, 932-939 (2002).
39. L sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8, 705-711 (2001).
40. Wei, M.C. et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14, 2060-2071 (2000).
41. Letai, A. et al. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183-192 (2002).
42. Yang, J. et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132 (1997).
43. Kluck, R.M., Bossy-Wetzel, E., Green, D.R. & Newmeyer, D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136 (1997).
44. Liu, X., Kim, C.N., Yang, J., Jemmerson, R. & Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157 (1996).
45. Du, C., Fang, M., Li, Y., Li, L. & Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42 (2000).
46. Verhagen, A.M. et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43-53 (2000).
47. Duckett, C.S. et al. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMB0 J. 15, 2685-2694 (1996).
48. Uren, A.G., Pakusch, M., Hawkins, C.J., Puls, K.L. & Vaux, D.L. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors, Proc. Natl. Acad. Sci. USA 93, 4974-4978 (1996).
49. Susin, S.A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446 (1999).
50. Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549-554 (2001).
51. Nagata, S. Apoptosis by death factor. Cell 88, 355-365 (1997).
52. Varfolomeev, E.E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267-276 (1998).
53. Scaffidi, C. et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687 (1998).
54. Strasser, A., Harris, A.W., Huang, D.C., Krammer, P.H. & Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147 (1995).
55. Li, H., Zhu, H., Xu, C.J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501 (1998).
56. Luo, X., Budihardjo, I., Zou, H., Slaughter, C. & Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490 (1998).
57. Yin, X.M. et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400, 886-891 (1999).
58. Zha, J., Weiler, S., Oh, K.J., Wei, M.C. & Korsmeyer, S.J. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290, 1761-1765 (2000).
59. Datta, S.R., Brunet, A. & Greenberg, M.E. Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927 (1999).
60. Kohn, A.D., Summers, S.A., Birnbaum, M.J. & Roth, R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-LI adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271, 31372-31378 (1996).
61. Wang, Q. et al. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19, 4008-4018 (1999).
62. Summers, S.A., Garza, L.A., Zhou, H. & Birnbaum, M.J. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol. Cell. Biol. 18, 5457-5464 (1998).
63. Harada, H., Andersen, J.S., Mann, M., Terada, N. & Korsmeyer, S.J. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc. Natl. Acad. Sci. USA 98, 9666-9670 (2001).
64. Harada, H. et. al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3, 413-422 (1999).
65. Shimamura, A., Ballif, B.A., Richards, S.A. & Blenis, J. Rsk1 mediates a MEK-MAP kinase survival signal. Curr. Biol. 10, 127-135 (2000).
66. Datta, S.R. et al. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev. Cell 3, 631-643 (2002).
67. Peschon, J.J. et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960 (1994).
68. von Freeden-Jeffry, U. et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526 (1995).
69. Zinkel, S.S. et al. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev. 17, 229-239 (2003).
70. Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735-1738 (1999).
71. Puthalakath, H., Huang, D.C., O'Reilly, L.A., King, S.M. & Strasser, A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3, 287-296 (1999).
72. Strasser, A., Harris, A.W. & Cory, S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67, 889-899 (1991).
73. Hildeman, D.A. et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16, 759-767 (2002).
74. Bouillet, P. et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415, 922-926 (2002).
75. Jiang, A. & Clark, E.A. Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis. J. Immunol. 166, 6025-6033 (2001).
76. Nakano, K. & Vousden, K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694 (2001).
77. Oda, E. et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-1058 (2000).
78. Yu, J., Zhang, L., Hwang, P.M., Kinzler, K.W. & Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673-682 (2001).
79. Yin, X.M., Oltvai, Z.N. & Korsmeyer, S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369, 321-323 (1994).
80. Gross, A., Jockel, J., Wei, M.C. & Korsmeyer, S.J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878-3885 (1998).
81. Veis, D.J., Sorenson, C.M., Shutter, J.R. & Korsmeyer, S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240 (1993).
82. Bouillet, P., Cory, S., Zhang, L.C., Strasser, A. & Adams, J.M. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev. Cell 1, 645-653 (2001).
83. Motoyama, N., Kimura, T., Takahashi, T., Watanabe, T. & Nakano, T. bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation. J. Exp. Med. 189, 1691-1698 (1999).
84. Veis, D.J., Sentman, C.L., Bach, E.A. & Korsmeyer, S.J. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151, 2546-2554 (1993).
85. L-regulated apoptosis in T cell development. Int. Immunol. 9, 1375-1384 (1997).
86. Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O. & Korsmeyer, S.J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888 (1991).
87. Strasser, A., Harris, A.W., von Boehmer, H. & Cory, S. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc. Natl. Acad. Sci. USA 91, 1376-1380 (1994).
88. Linette, G.P., Hess, J.L., Sentman, C.L. & Korsmeyer, S.J. Peripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice. Blood 86, 1255-1260 (1995).
89. + stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1, 197-205 (1994).
90. Strasser, A., Harris, A.W., Corcoran, L.M. & Cory, S. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature 368, 457-460 (1994).
91. Newton, K., Harris, A.W., Bath, M.L., Smith, K.G. & Strasser, A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17, 706-718 (1998).
92. Maraskovsky, E., Peschon, J.J., McKenna, H., Teepe, M. & Strasser, A. Overexpression of Bcl-2 does not rescue impaired B lymphopoiesis in IL-7 receptor-deficient mice but can enhance survival of mature B cells. Int. Immunol. 10, 1367-1375 (1998).
93. Kondo, M., Akashi, K., Domen, J., Sugamura, K. & Weissman, I.L. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common γ chair-deficient mice. Immunity 7, 155-162 (1997).
94. Ranger, A.M., Malynn, B.A. & Korsmeyer, S.J. Mouse models of cell death. Nat. Genet. 28, 113-118 (2001).
95. Hara, H. et al. The apoptotic protease-activating factor I-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. J. Immunol. 168, 2288-2295 (2002).
96. Marsden, V.S. et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419, 634-637 (2002).
97. Kuida, K. et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-372 (1996).
98. Woo, M. et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12, 806-819 (1998).
99. Yeh, W.C. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954-1958 (1998).
100. Zhang, J., Cado, D., Chen, A., Kabra, N.H. & Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300 (1998).
101. L modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol. Cell. Biol. 22, 5419-5433 (2002).